TG Therapeutics Inc.
TGTX | NASDAQ
$57.16
+$0.29 (+0.51%)
At close: Sep 21, 2026, 4:00 PM ET
$57.44
+$0.28 (+0.49%)
Pre-market:
Sep 22, 2026, 8:16 AM ET
TTM Period Ending | Q2 2026 Jun 29, 2026 | Q1 2026 Mar 30, 2026 | Q4 2025 Dec 30, 2025 | Q3 2025 Sep 29, 2025 | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 | Q3 2023 Sep 29, 2023 | Q2 2023 Jun 29, 2023 | Q1 2023 Mar 30, 2023 | Q4 2022 Dec 30, 2022 | Q3 2022 Sep 29, 2022 | Q2 2022 Jun 29, 2022 | Q1 2022 Mar 30, 2022 | Q4 2021 Dec 30, 2021 | Q3 2021 Sep 29, 2021 | Q2 2021 Jun 29, 2021 | Q1 2021 Mar 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 799.54M | 700.35M | 616.29M | 531.9M | 454.07M | 386.39M | 329M | 264.79M | 346.73M | 289.33M | 233.66M | 189.77M | 24.05M | 8.57M | 2.78M | 5.03M | 6.96M | 7.91M | 6.69M | 4.41M | 2.41M | 907K |
Cost of Revenue | 141M | 118.75M | 100.78M | 78.03M | 59.22M | 48.59M | 38.57M | 31.11M | 25.28M | 18.89M | 14.22M | 6.28M | 2.77M | 885K | 265K | 472K | 762K | 887K | 789K | 685K | 393K | 245K |
Gross Profit | 658.54M | 581.6M | 515.51M | 453.87M | 394.85M | 337.8M | 290.44M | 233.68M | 321.44M | 270.45M | 219.44M | 183.49M | 21.28M | 7.69M | 2.52M | 4.55M | 6.2M | 7.03M | 5.9M | 3.72M | 2.02M | 662K |
Operating Income | 136.33M | 149.5M | 123.32M | 102.78M | 85.85M | 59.82M | 41.93M | -505K | 101.85M | 48.36M | 20.63M | -18.94M | -168.69M | -162.96M | -192.84M | -233.72M | -283.89M | -322.44M | -344.77M | -338.6M | -339.2M | -312.55M |
Interest Income | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Income | 101.6M | 122.29M | 107.39M | 87.75M | 66.11M | 41.74M | 25.59M | -13.89M | 95.78M | 41.62M | 13.06M | -25.91M | -175.65M | -168.55M | -198.34M | -238.68M | -288.5M | -326.48M | -348.1M | -342.98M | -344.51M | -318.89M |
Net Income | 441.49M | 461.9M | 447.18M | 447.47M | 60.46M | 39.15M | 23.38M | -14.36M | 95.69M | 41.2M | 12.67M | -25.91M | -175.65M | -168.55M | -198.34M | -238.68M | -288.5M | -326.49M | -348.1M | -342.98M | -344.51M | -318.89M |
Selling & General & Admin | 296.4M | 269.86M | 231.97M | 208.19M | 186.85M | 169.98M | 154.15M | 146.24M | 137.05M | 134.71M | 128.28M | 119.72M | 101.21M | 77.46M | 70.01M | 79.91M | 100.56M | 121.94M | 128.09M | 139.43M | 139.83M | 120.25M |
Research & Development | 225.8M | 162.25M | 160.22M | 142.9M | 122.16M | 107.93M | 94.29M | 87.87M | 82.48M | 87.38M | 70.53M | 82.72M | 88.76M | 93.18M | 125.35M | 158.36M | 189.53M | 207.53M | 222.58M | 202.89M | 201.39M | 192.97M |
Other Expenses | n/a | n/a | n/a | n/a | n/a | 72K | 72K | 72K | 72K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 1K | 1K | 1K | 1K | n/a |
Operating Expenses | 522.21M | 432.11M | 392.19M | 351.09M | 309M | 277.98M | 248.51M | 234.18M | 219.6M | 222.09M | 198.81M | 202.44M | 189.97M | 170.64M | 195.36M | 238.28M | 290.09M | 329.46M | 350.67M | 342.33M | 341.22M | 313.21M |
Interest Expense | 37.49M | 27.64M | 26.73M | 27.26M | 31.37M | 28.63M | 24.16M | 19.53M | 12.41M | 12.06M | 12.62M | 13.05M | 10.98M | 10.37M | 10.19M | 8.41M | 7.8M | 6.4M | 5.64M | 5.85M | 6.42M | 7.03M |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | -72K | -154K | -3.09M | -3.09M | -3.02M | -2.94M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 663.21M | 550.85M | 492.96M | 429.12M | 368.22M | 326.57M | 287.08M | 265.3M | 244.88M | 240.98M | 213.03M | 208.72M | 192.74M | 171.53M | 195.62M | 238.75M | 290.85M | 330.35M | 351.46M | 343.01M | 341.61M | 313.46M |
Income Tax Expense | -339.89M | -339.61M | -339.79M | -359.72M | 5.65M | 2.59M | 2.21M | 479K | 91K | 419K | 390K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Shares Outstanding (Basic) | 141.77M | 144.44M | 142.96M | 145.42M | 146.74M | 146.68M | 145.24M | 145.1M | 144.73M | 146.21M | 143.09M | 142.87M | 141.5M | 140.31M | 137.11M | 135.33M | 137.78M | 134.4M | 132.56M | 132.35M | 132.07M | 131.9M |
Shares Outstanding (Diluted) | 157.28M | 160.06M | 159.37M | 161M | 162.56M | 162.77M | 160.24M | 160.71M | 159.42M | 146.21M | 143.09M | 155.87M | 141.5M | 140.31M | 137.11M | 135.33M | 137.78M | 134.4M | 132.56M | 132.35M | 132.07M | 131.9M |
EPS (Basic) | 3.04 | 3.18 | 3.07 | 3.07 | 0.41 | 0.27 | 0.16 | -0.10 | 0.67 | 0.29 | 0.08 | -0.21 | -1.27 | -1.23 | -1.46 | -1.77 | -2.16 | -2.45 | -2.63 | -2.64 | -2.72 | -2.60 |
EPS (Diluted) | 2.74 | 2.86 | 2.77 | 2.78 | 0.37 | 0.24 | 0.14 | -0.11 | 0.60 | 0.22 | 0.01 | -0.28 | -1.27 | -1.23 | -1.46 | -1.77 | -2.16 | -2.45 | -2.63 | -2.64 | -2.72 | -2.60 |
EBITDA | 134.17M | 150.19M | 134.36M | 115.24M | 97.72M | 70.62M | 50.03M | 5.95M | 108.56M | 54.06M | 26.1M | -12.4M | -164.21M | -157.68M | -187.63M | -229.75M | -280.18M | -319.57M | -341.97M | -336.66M | -337.65M | -311.46M |
EBIT | 133.96M | 149.92M | 134.12M | 115.01M | 97.48M | 70.37M | 49.75M | 5.64M | 108.19M | 53.68M | 25.68M | -12.86M | -164.67M | -158.18M | -188.14M | -230.27M | -280.7M | -320.08M | -342.46M | -337.13M | -338.08M | -311.87M |
Depreciation & Amortization | 209K | 268K | 244K | 239K | 241K | 254K | 280K | 309K | 371K | 384K | 423K | 458K | 461K | 507K | 515K | 522K | 522K | 511K | 494K | 467K | 432K | 402K |
Add to Watchlist
Select watchlists to add or remove TGTX